Senior insider sale
Chief Clinical Officer at PENNANT GROUP, INC. — senior position signals high conviction
$53.7K
1.39K shares
What this filing means
STEIK JASON PAUL plans to sell 1.39K shares of PENNANT GROUP, INC. valued at approximately $53.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/6/2026ACC: 0001959173-26-005716
Officer· Chief Clinical Officer
Since Mar 2026
1.39K
Shares to sell
$53.7K
Approx. market value
1.39K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
7/27/2026
1.39KTotal acquired1.39K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/27/2026 | Restricted Stock Vesting Compensation | 1.39K | — |
| Total | 1.39K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.39K
Market value
$53.7K
8/6/2026
Total
Units
1.39K
Value
$53.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/6/2026 | 1.39K | $53.7K | NASDAQ | Planned |
| Total | 1.39K | $53.7K | ||